Recruiting studies: Statin Adverse Reaction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

DESIFOR-EXPAND (MHIF)
Phase 4 · 1 location(s) · Minneapolis Heart Institute Foundation · NCT06804980 Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164 Hepatic Safety of Statin Use in Neurology Inpatients
Phase N/A · 1 location(s) · Shanghai Yueyang Integrated Medicine Hospital · NCT06592196 Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Phase 4 · 7 location(s) · Kiyuk Chang, MD,PhD · NCT04499859 Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
Phase 1 · 1 location(s) · Virginia Commonwealth University · NCT06874192 Exercise Intensity and Muscle Recovery in Statin Users
NA · 1 location(s) · Raffaele Mazzolari · NCT07563452

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.